The Ensign Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$ENSG
Hospital/Nursing Management
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 2025
The Ensign Group, Inc .
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||||||||
Registrant's telephone number, including area code: (949 ) 487-9500
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
The 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of The Ensign Group, Inc. (the “Company”) was held on May 15, 2025. The number of issued and outstanding shares of the Company’s common stock entitled to vote at the Annual Meeting was 57,626,065. These shares were issued and outstanding as of March 20, 2025, which was the record date for the Annual Meeting. There were present at the Annual Meeting, either in person or by proxy, 53,021,533 shares of the Company’s common stock. The matters voted upon at the Annual Meeting and the results of the votes were as follows:
1.The four nominees named below were elected to serve as Class II or Class III directors of the board of directors, as set forth below, to serve until the 2027 and 2028 Annual Meeting, until a successor is elected and qualified, and the voting results were as follows:
| Votes | Votes | Broker | ||||||||||||||||||||||||
| Nominee | For | Against | Abstentions | Non-Votes | ||||||||||||||||||||||
| Class II director elected for a two-year term | ||||||||||||||||||||||||||
| Mr. Mark V. Parkinson | 49,110,416 | 1,037,569 | 29,494 | 2,844,054 | ||||||||||||||||||||||
| Class III director elected for a three-year term | ||||||||||||||||||||||||||
| Dr. Ann S. Blouin | 47,727,307 | 2,371,159 | 79,013 | 2,844,054 | ||||||||||||||||||||||
| Dr. John O. Agwunobi | 49,240,959 | 902,310 | 34,210 | 2,844,054 | ||||||||||||||||||||||
| Mr. Barry R. Port | 49,332,141 | 800,871 | 44,467 | 2,844,054 | ||||||||||||||||||||||
2. The selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025 was ratified, and the voting results were as follows:
| Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||||||||
| 51,829,096 | 1,165,541 | 26,896 | — | |||||||||||||||||
3. The compensation paid to the company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, was approved on an advisory basis, and the voting results were as follows:
| Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||||||||
| 47,594,403 | 2,545,099 | 37,977 | 2,844,054 | |||||||||||||||||
4. The amendment to the Ensign Group, Inc. 2022 Omnibus Incentive Plan was approved, and the voting results were as follows:
| Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||||||||
| 47,871,232 | 2,268,901 | 37,346 | 2,844,054 | |||||||||||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE ENSIGN GROUP, INC. | ||||||||
Dated: May 20, 2025 | /s/ Chad A. Keetch | |||||||
| Chad A. Keetch | ||||||||
| Chief Investment Officer | ||||||||